Long Term Follow up for the Detection of Delayed Adverse Events in Cal-1 Recipients

Safety and Survival of Genetically Modified White Blood Cells in HIV-Infected Persons - A Study in Identical Twin Pairs

NCT00001353 ·Status: COMPLETED

An Expanded Access Open Label Protocol of Remune (HIV-1 Immunogen) in HIV-1-Infected Adults With CD4 Count 550 Cells /Ml and Greater.

NCT00002173 ·Status: COMPLETED ·Phase: NA

A Trial of Anti-CD4 Antibody UB-421 in Combination With Optimized Background Antiretroviral Therapy in Patients With Multi-Drug Resistant HIV-1 Infection

NCT05582694 ·Status: WITHDRAWN ·Phase: PHASE2

Lymphocyte Infusions for the Treatment of HIV-Infected Patients Failing Anti-HIV Therapy

NCT00559416 ·Status: TERMINATED ·Phase: PHASE1

A Study of Cytotoxic T Lymphocyte (CTL) Therapy in HIV-Infected Patients

NCT00000824 ·Status: TERMINATED ·Phase: NA

Selection of a Protective T Cell-based HIV-1/FIV Vaccine

NCT02389595 ·Status: ACTIVE_NOT_RECRUITING

Gene Transfer for HIV Using Autologous T Cells

NCT01153646 ·Status: TERMINATED ·Phase: EARLY_PHASE1

An Expanded Access Open-Label, Compassionate Use Protocol of Remune in HIV-1-Infected Adults With CD4 Count Less Than 300 Cells/Ml

NCT00002172 ·Status: COMPLETED ·Phase: NA

Advancing Dignity, Health, and Optimism in Connection With Long Acting Injectables

NCT05208541 ·Status: RECRUITING

Genetically Modified Lymphocytes to Treat HIV-Infected Identical Twins - Study Modifications

NCT00001409 ·Status: COMPLETED ·Phase: PHASE1

Leniolisib for Immune Dysregulation in CVID

NCT06897358 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

CAR-T Cells for HIV Infection

NCT04648046 ·Status: RECRUITING ·Phase: PHASE1/PHASE2

Safety and Immune Response of BMS-936559 in HIV-Infected People Taking Combination Antiretroviral Therapy

NCT02028403 ·Status: COMPLETED ·Phase: PHASE1

A Clinical Trial in Healthy, HIV-1-Uninfected Adult Participants to Compare the Safety, Tolerability and Immunogenicity of CH505TF gp120 Produced From Stably Transfected Cells to CH505TF gp120 Produced From Transiently Transfected Cells

NCT03856996 ·Status: COMPLETED ·Phase: PHASE1

Gene Therapy in Treating Patients With Human Immunodeficiency Virus-Related Lymphoma Receiving Stem Cell Transplant

NCT02797470 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1/PHASE2

A Multicenter, Double-Blind, Phase III, Adjuvant-Controlled Study of the Effect of 10 Units of HIV-1 Immunogen (Remune) Compared to Incomplete Freund's Adjuvant (IFA) Alone Every 12 Weeks on AIDS-Free Survival in Subjects With HIV Infection and CD4 T-Lymphocytes Between 300 and 549 Cells/microL Rega

NCT00002359 ·Status: COMPLETED ·Phase: PHASE3

Safety, PK and Antiviral Activity of PGT121 Monoclonal Antibody in HIV-uninfected and HIV-infected Adults

NCT02960581 ·Status: COMPLETED ·Phase: PHASE1

Twins Study of Gene Therapy for HIV Infection

NCT00001535 ·Status: COMPLETED ·Phase: PHASE1

Long-term Follow-up of Long-acting Cabotegravir (CAB LA) for PrEP (Pre-exposure Prophylaxis) in Participants at Risk of Acquiring HIV (Human Immunodeficiency Virus)

NCT06134362 ·Status: RECRUITING ·Phase: PHASE3

Human Immune Responses Toward HIV-1 Envelope Antigens

NCT01344941 ·Status: COMPLETED

Analysis of Immune Responses to HIV Vaccines

NCT00068978 ·Status: COMPLETED

Leukapheresis to Obtain Plasma or Lymphocytes for Studies of HIV-infected Patients, Including Long-term Non-progressors

NCT00029445 ·Status: RECRUITING

Study of Anti-HIV Therapy Intensification

NCT00034086 ·Status: COMPLETED ·Phase: NA

Umbrella Study for HIV Infected Adults Enrolled in NIAID-Funded Interleukin-2 Studies

NCT00311688 ·Status: COMPLETED

Leukapheresis Procedures to Obtain Plasma and Lymphocytes for Research Studies on Antiretroviral Naive HIV-1 Research Participants

NCT00039689 ·Status: RECRUITING